|
1
|
Schwab JH, Springfield DS, Raskin KA,
Mankin HJ and Hornicek FJ: What's new in primary bone tumors. J
Bone Joint Surg Am. 94:1913–1919. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cho Y, Jung GH, Chung SH, Kim JY, Choi Y
and Kim JD: Long-term survivals of stage IIb osteosarcoma: A
20-year experience in a single institution. Clin Orthop Surg.
3:48–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lewis VO: What's new in musculoskeletal
oncology. J Bone Joint Surg Am. 91:1546–1556. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wada T, Isu K, Takeda N, Usui M, Ishii S
and Yamawaki S: A preliminary report of neoadjuvant chemotherapy
NSH-7 study in osteosarcoma: Preoperative salvage chemotherapy
based on clinical tumor response and the use of granulocyte
colony-stimulating factor. Oncology. 53:221–227. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dikic I, Wakatsuki S and Walters KJ:
Ubiquitin-binding domains - from structures to functions. Nat Rev
Mol Cell Biol. 10:659–671. 2009. View
Article : Google Scholar
|
|
7
|
Raasi S, Schmidtke G and Groettrup M: The
ubiquitin-like protein FAT10 forms covalent conjugates and induces
apoptosis. J Biol Chem. 276:35334–35343. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hipp MS, Kalveram B, Raasi S, Groettrup M
and Schmidtke G: FAT10, a ubiquitin-independent signal for
proteasomal degradation. Mol Cell Biol. 25:3483–3491. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren J, Wang Y, Gao Y, Mehta SB and Lee CG:
FAT10 mediates the effect of TNF-α in inducing chromosomal
instability. J Cell Sci. 124:3665–3675. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Merbl Y, Refour P, Patel H, Springer M and
Kirschner MW: Profiling of ubiquitin-like modifications reveals
features of mitotic control. Cell. 152:1160–1172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji F, Jin X, Jiao CH, Xu QW, Wang ZW and
Chen YL: FAT10 level in human gastric cancer and its relation with
mutant p53 level, lymph node metastasis and TNM staging. World J
Gastroenterol. 15:2228–2233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL,
Yong Tan S, Kan A, Nuchprayoon I, Jin R, Lee KH, et al: Expression
of the FAT10 gene is highly upregulated in hepatocellular carcinoma
and other gastrointestinal and gynecological cancers. Oncogene.
22:2592–2603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lukasiak S, Schiller C, Oehlschlaeger P,
Schmidtke G, Krause P, Legler DF, Autschbach F, Schirmacher P,
Breuhahn K and Groettrup M: Proinflammatory cytokines cause FAT10
upregulation in cancers of liver and colon. Oncogene. 27:6068–6074.
2008. View Article : Google Scholar
|
|
14
|
Sun GH, Liu YD, Yu G, Li N, Sun X and Yang
J: Increased FAT10 expression is related to poor prognosis in
pancreatic ductal adenocarcinoma. Tumour Biol. 35:5167–5171. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan J, Tu Y, Mao X, He S, Wang L, Fu G,
Zong J and Zhang Y: Increased expression of FAT10 is correlated
with progression and prognosis of human glioma. Pathol Oncol Res.
18:833–839. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan R, Wang K, Hu J, Yan C, Li M, Yu X,
Liu X, Lei J, Guo W, Wu L, et al: Ubiquitin-like protein FAT10
promotes the invasion and metastasis of hepatocellular carcinoma by
modifying β-catenin degradation. Cancer Res. 74:5287–5300. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abate-Shen C: Deregulated homeobox gene
expression in cancer: Cause or consequence? Nat Rev Cancer.
2:777–785. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nguyen DX, Chiang AC, Zhang XH, Kim JY,
Kris MG, Ladany M, Gerald WL and Massagué J: WNT/TCF signaling
through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
Cell. 138:51–62. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hayashida T, Takahashi F, Chiba N,
Brachtel E, Takahashi M, Godin-Heymann N, Gross KW, Vivanco M,
Wijendran V, Shioda T, et al: HOXB9, a gene overexpressed in breast
cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad
Sci USA. 107:1100–1105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wen M, Kwon Y, Wang Y, Mao JH and Wei G:
Elevated expression of UBE2T exhibits oncogenic properties in human
prostate cancer. Oncotarget. 6:25226–25239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Guessous F, Johnson EB, Eberhart CG,
Li XN, Shu Q, Fan S, Lal B, Laterra J, Schiff D, et al: Functional
and molecular interactions between the HGF/c-Met pathway and c-Myc
in large-cell medulloblastoma. Lab Invest. 88:98–111. 2008.
View Article : Google Scholar
|
|
22
|
Gao Y, Theng SS, Zhuo J, Teo WB, Ren J and
Lee CG: FAT10, an ubiquitin-like protein, confers malignant
properties in non-tumorigenic and tumorigenic cells.
Carcinogenesis. 35:923–934. 2014. View Article : Google Scholar
|
|
23
|
Liu L, Dong Z, Liang J, Cao C, Sun J, Ding
Y and Wu D: As an independent prognostic factor, FAT10 promotes
hepatitis B virus-related hepatocellular carcinoma progression via
Akt/GSK3β pathway. Oncogene. 33:909–920. 2014. View Article : Google Scholar
|
|
24
|
Hatzis P, van der Flier LG, van Driel MA,
Guryev V, Nielsen F, Denissov S, Nijman IJ, Koster J, Santo EE,
Welboren W, et al: Genome-wide pattern of TCF7L2/TCF4 chromatin
occupancy in colorectal cancer cells. Mol Cell Biol. 28:2732–2744.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miki T, Yasuda SY and Kahn M:
Wnt/β-catenin signaling in embryonic stem cell self-renewal and
somatic cell reprogramming. Stem Cell Rev. 7:836–846. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lai TY, Su CC, Kuo WW, Yeh YL, Kuo WH,
Tsai FJ, Tsai CH, Weng YJ, Huang CY and Chen LM: β-catenin plays a
key role in metastasis of human hepatocellular carcinoma. Oncol
Rep. 26:415–422. 2011.PubMed/NCBI
|
|
27
|
Lin SY, Xia W, Wang JC, Kwong KY, Spohn B,
Wen Y, Pestell RG and Hung MC: Beta-catenin, a novel prognostic
marker for breast cancer: Its roles in cyclin D1 expression and
cancer progression. Proc Natl Acad Sci USA. 97:4262–4266. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Polakis P: The oncogenic activation of
beta-catenin. Curr Opin Genet Dev. 9:15–21. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rubinfeld B, Robbins P, El-Gamil M, Albert
I, Porfiri E and Polakis P: Stabilization of beta-catenin by
genetic defects in melanoma cell lines. Science. 275:1790–1792.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aberle H, Bauer A, Stappert J, Kispert A
and Kemler R: beta-catenin is a target for the ubiquitin-proteasome
pathway. EMBO J. 16:3797–3804. 1997. View Article : Google Scholar : PubMed/NCBI
|
